The Impact of Comorbid HIV infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Breast Cancer Patients

被引：0
|
作者：
O'Neil, Daniel S.
Ayeni, Oluwatosin A.
Woolridge, Hayley A. Farrow
Chen, Wenlong Carl
Demetriou, Georgia
Buccimazza, Ines
Cacala, Sharon
Joffe, Maureen
Antoni, Michael
Lopes, Gilberto
Pumpalova, Yoanna
Mapanga, Witness
Jacobson, Judith S.
Crew, Katherine D.
Neugut, Alfred I.
Ruff, Paul
Cubasch, Herbert
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P1-01-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-01-03
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer
    O'Neil, Daniel S.
    Ayeni, Oluwatosin A.
    Farrow, Hayley A.
    Chen, Wenlong Carl
    Demetriou, Georgia
    Buccimazza, Ines
    Cacala, Sharon
    Stopforth, Laura W.
    Joffe, Maureen
    Antoni, Michael H.
    Lopes, Gilberto
    Pumpalova, Yoanna S.
    Mapanga, Witness
    Jacobson, Judith S.
    Crew, Katherine D.
    Neugut, Alfred, I
    Ruff, Paul
    Cubasch, Herbert
    ONCOLOGIST, 2023, 28 (10): : e921 - e929
  • [2] Adjuvant chemotherapy for breast cancer - prognostic impact of relative dose-intensity
    Kahlert, S.
    Rosenfeld, J.
    Mair, K.
    Sorokina, Y.
    Engel, J.
    Friese, K.
    CANCER RESEARCH, 2009, 69 (02) : 283S - 283S
  • [3] Relative dose intensity reduction in breast cancer adjuvant chemotherapy
    Faustino, C.
    Afonso, N.
    Sousa, B.
    Espirito, Santo J.
    Rodrigues, H.
    CANCER RESEARCH, 2009, 69 (02) : 283S - 284S
  • [4] The impact of chemotherapy relative dose intensity on pathological complete response in patients with triple negative breast cancer treated with neoadjuvant chemotherapy
    Buonaiuto, Roberto
    Neola, Giuseppe
    Caltavituro, Aldo
    Trasacco, Paola
    Mangiacotti, Federica Pia
    Pecoraro, Giovanna
    Lambertini, Matteo
    Pietroluongo, Erica
    De Placido, Pietro
    De Placido, Sabino
    Forestieri, Valeria
    Giuliano, Mario
    Arpino, Grazia
    De Angelis, Carmine
    CANCER RESEARCH, 2024, 84 (09)
  • [5] Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy
    Martei, Yehoda M.
    Narasimhamurthy, Mohan
    Setlhako, Dipho, I
    Ayane, Gezahen
    Ralefala, Tlotlo
    Chiyapo, Sebathu
    Gross, Robert
    Shulman, Lawrence N.
    Grover, Surbhi
    DeMichele, Angela
    JCO GLOBAL ONCOLOGY, 2022, 8
  • [6] Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIV
    O'Neil, Daniel S.
    Martei, Yehoda M.
    Crew, Katherine D.
    Castillo, Brenda S.
    Costa, Philippos
    Lim, Tristan
    Michel, Alissa
    Rubin, Elizabeth
    Goel, Neha
    Hurley, Judith
    Lopes, Gilberto
    Antoni, Michael H.
    JAMA NETWORK OPEN, 2023, 6 (12) : E2346223
  • [7] Relative dose intensity (RDI) relevance in adjuvant CMF chemotherapy of breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 155 - 155
  • [8] Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices
    Denduluri, Neelima
    Patt, Debra A.
    Wang, Yunfei
    Bhor, Menaka
    Li, Xiaoyan
    Favret, Anne M.
    Morrow, Phuong Khanh
    Barron, Richard L.
    Asmar, Lina
    Saravanan, Shanmugapriya
    Li, Yanli
    Garcia, Jacob
    Lyman, Gary H.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (11): : 1383 - +
  • [9] Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer
    Ladwa, Rahul
    Kalas, Timothy
    Pathmanathan, Shivanshan
    Woodward, Natasha
    Wyld, David
    Sanmugarajah, Jasotha
    CLINICAL BREAST CANCER, 2018, 18 (05) : E1181 - E1187
  • [10] Dose intensity and downstaging in breast cancer neoadjuvant chemotherapy
    Shparik, J
    Bilynsky, B
    Kovalchuk, I
    BRITISH JOURNAL OF CANCER, 1996, 74 : PO29 - PO29
12345